REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
18/05/2026
Voltar para busca
Dado oficial do USPTO
KIRIN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
19/05/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
23/04/2019
Data de registro
18/05/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/05/2021
Última transação
19/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
03
Localização do titular
JP
Examinador
NIEMANN, SHELBY LYNN
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Kirin Holdings Kabushiki Kaisha (also trading as Kirin Holdings Company, Limited)
Representantes
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Milk ferments for pharmaceutical purposes; collyrium; nasal spray preparations for medical purposes; nasal spray preparations; vaginal pharmaceutical preparations for treating fungal infections; pharmaceutical antitussive-cold preparations; preparations for destroying vermin; fungicides; herbicides; pharmaceutical preparations for the treatment of gastrointestinal diseasescancerbacterial skin infectionsvitamin deficienciesintestinal bacteriainfluenzacoldsphysical disordersfatigueanemialeukopeniahyperphosphatemiahyperparathyroidismleukemiainfluenzaHIVmyelodysplastic syndromehepatitis virus infection and autoimmune hepatitis; pharmaceutical preparations for mobilization of peripheral blood progenitor cells; pharmaceutical preparations for conditioning treatment prior to hematopoietic stem cell transplantation; medical and veterinary preparationsdiagnosticbacterialbacteriological preparations for medical or veterinary purposes; vitamin preparationsnot for pain relief or cosmetic purposes; vitamin substances in the nature of vitamin supplementsnot for pain relief or cosmetic purposes; nutritional additives for medical purposesnot for pain relief or cosmetic purposes; medicinal tonics and substitutes therefordietary supplements for humans and animalsnot for pain relief or cosmetic purposes; calcium pharmaceutical preparations in the nature of calcium supplementsnot for pain relief or cosmetic purposes; reagent paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; capsules sold empty for pharmaceuticals; mothproofing paper; lacteal flour for babies; dietary and nutritional supplements in tabletchewablepowdercapsuleliquid or gel formnot for pain relief or cosmetic purposes; lactic acid bacteria-based food supplements in geltabletchewablepowdercapsule or liquid formnot for pain relief or cosmetic purposes; dietary and nutritional supplementsnot for pain relief or cosmetic purposes; dietetic pharmaceuticalsdietetic foods and beverages adapted for medical or veterinary use; dietetic food adapted for medical purposesfood for chewing and swallowing disorders; food thickener for dysphagia for medical purposesfood additives in the nature of glucose and lecithin for medical purposes for assistance with swallowing; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babiesdietary supplement beverages for aiding sleep and promoting digestion for babies; food for babies; nutritional supplements for animal foodstuffsnot for pain relief or cosmetic purposes; dietary supplements for animalsnot for pain relief or cosmetic purposes; semen for artificial insemination; cultures of microorganisms for medical or veterinary use
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/05/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/10/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/09/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
01/09/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/08/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
18/05/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
27/03/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/03/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/03/2021
PUBO
PUBLISHED FOR OPPOSITION
02/03/2021
GPNX
NOTIFICATION PROCESSED BY IB
01/03/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/02/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/02/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/02/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/06/2020
GNRT
NON-FINAL ACTION E-MAILED
11/06/2020
CNRT
NON-FINAL ACTION WRITTEN
11/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/05/2020
ALIE
ASSIGNED TO LIE
11/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/05/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/05/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/05/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/05/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/05/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/05/2020
RFNT
REFUSAL PROCESSED BY IB
22/11/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/11/2019
RFRR
REFUSAL PROCESSED BY MPU
06/11/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/10/2019
MAFR
APPLICATION FILING RECEIPT MAILED
22/10/2019
CNRT
NON-FINAL ACTION WRITTEN
21/10/2019
DOCK
ASSIGNED TO EXAMINER
16/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/10/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/10/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KIRIN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.